TigerOak Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12M Sell
9,613
-238
-2% -$65.8K 0.6% 27
2026
Q1
$2.91M Buy
9,851
+33
+0.3% +$9.8K 0.92% 20
2025
Q4
$2.68M Sell
9,818
-161
-2% -$43.7K 0.82% 21
2025
Q3
$2.7M Sell
9,979
-143
-1% -$38.9K 0.84% 21
2025
Q2
$2.79M Buy
10,122
+218
+2% +$59.3K 0.96% 21
2025
Q1
$2.63M Sell
9,904
-40
-0.4% -$9.87K 1.01% 19
2024
Q4
$2.31M Buy
+9,944
New +$2.29M 0.84% 21

Other funds holding CME

TigerOak Management's CME Position: Q2 2026 in Review

TigerOak Management reduced its CME Group (CME) stake by 2.4% in Q2 2026, selling an estimated $65.8K and leaving 9,613 shares worth $2.12M. The position accounts for 0.6% of the portfolio, ranked #27.

TigerOak Management first reported a position in CME in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.91M in Q1 2026. 1,703 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • TigerOak Management held 9,613 shares of CME Group worth $2.12M as of Q2 2026.
  • TigerOak Management sold 238 CME Group shares in Q2 2026, an estimated $65.8K.
  • CME Group made up 0.6% of TigerOak Management's portfolio in Q2 2026, its #27 holding.
  • TigerOak Management first reported a position in CME Group in Q4 2024 and has held it in 7 quarters since.
  • TigerOak Management's CME Group position peaked at $2.91M in Q1 2026.
  • 1,703 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on TigerOak Management's 13F filing for Q2 2026, filed 11 Aug 2026.